Skyrizi
- Product NDC
- 0074-8350
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- risankizumab-rzaa
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- AbbVie Inc.
- Application
- BLA761105
- Marketing category
- BLA
- Substance
- RISANKIZUMAB
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 0074-8350-01 | 2 SYRINGE in 1 CARTON (0074-8350-01) / 1.2 mL in 1 SYRINGE | 2025-09-03 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Skyrizi | AbbVie Inc. | 2026-03-19 | HUMAN PRESCRIPTION DRUG LABEL | 173 |